Influence of Ku86 and XRCC4 expression in uterine cervical cancer on the response to preoperative radiotherapy

[1]  Kendra Johnson,et al.  Integration of and adherence to National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) in a Community Cancer Center , 2015 .

[2]  V. Valentini,et al.  Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study. , 2014, International journal of radiation oncology, biology, physics.

[3]  Y. Matsumoto,et al.  Analysis and results of Ku and XRCC4 expression in hypopharyngeal cancer tissues treated with chemoradiotherapy. , 2012, Oncology letters.

[4]  S. Jackson,et al.  Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. , 2011, Genes & development.

[5]  Y. Matsumoto,et al.  Radiation-induced XRCC4 association with chromatin DNA analyzed by biochemical fractionation. , 2010, Journal of radiation research.

[6]  H. Yamazaki,et al.  Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000. , 2006, International journal of radiation oncology, biology, physics.

[7]  Parker,et al.  Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. , 2003, European journal of cancer.

[8]  Y. Hosoi,et al.  The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma , 2002, Cancer.

[9]  Y. Hosoi,et al.  DNA-dependent protein kinase activity correlates with Ku70 expression and radiation sensitivity in esophageal cancer cell lines. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  P. Jeggo.  Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. , 1998, Radiation research.

[11]  P. Grigsby,et al.  Prophylactic Extended-Field Irradiation of Para-aortic Lymph Nodes in Stages IIB and Bulky IB and IIA Cervical Carcinomas: Ten-Year Treatment Results of RTOG 79-20 , 1995 .

[12]  K. Hatch,et al.  Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients. , 1991, Gynecologic oncology.

[13]  Arlan F. Fuller,et al.  Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for Stage IB and IIA carcinoma of the cervix , 1989 .

[14]  Cfccm-Anacccmac Neoadjuvant.  Neoadjuvant chemotherapy for locally advanced cervical cancer: A systematic review and meta-analysis of individual patient data from 21 randomised trials , 2003 .

[15]  F. Landoni,et al.  Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Y. Hosoi,et al.  Expression of genes involved in repair of DNA double-strand breaks in normal and tumor tissues. , 2001, International journal of radiation oncology, biology, physics.

[17]  S. Lees-Miller.  The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.